Novel Treatment of Yttrium-90 Radioembolization-Induced Liver Disease With Defibrotide in a Pediatric Liver Transplant Recipient
- PMID: 40776417
- DOI: 10.1002/pbc.31974
Novel Treatment of Yttrium-90 Radioembolization-Induced Liver Disease With Defibrotide in a Pediatric Liver Transplant Recipient
Similar articles
-
Yttrium-90 Transarterial Radioembolization as a Bridging Therapy to Liver Transplant in a Toddler With Pretreatment Extent (PRETEXT) IV Hepatoblastoma.Cureus. 2025 Jul 1;17(7):e87107. doi: 10.7759/cureus.87107. eCollection 2025 Jul. Cureus. 2025. PMID: 40755645 Free PMC article.
-
Prognostic value of CT-based skeletal muscle and adipose tissue mass and quality parameters in patients with liver metastases and intrahepatic cholangiocarcinoma undergoing Yttrium-90 radioembolization.Eur Radiol. 2025 Mar;35(3):1415-1427. doi: 10.1007/s00330-025-11349-y. Epub 2025 Jan 21. Eur Radiol. 2025. PMID: 39838088 Free PMC article.
-
Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.Eur J Surg Oncol. 2015 Jan;41(1):120-7. doi: 10.1016/j.ejso.2014.09.007. Epub 2014 Oct 7. Eur J Surg Oncol. 2015. PMID: 25449754 Free PMC article.
-
A systematic review of yttrium-90 radioembolization for unresectable liver metastases of melanoma.Eur J Radiol. 2017 Jul;92:111-115. doi: 10.1016/j.ejrad.2017.05.005. Epub 2017 May 4. Eur J Radiol. 2017. PMID: 28624008
-
Yttrium-90 radioembolization for unresectable metastatic neuroendocrine liver tumor: A systematic review.Eur J Radiol. 2018 Mar;100:23-29. doi: 10.1016/j.ejrad.2018.01.012. Epub 2018 Jan 9. Eur J Radiol. 2018. PMID: 29496075
Publication types
LinkOut - more resources
Full Text Sources